Nuvo Pharmaceuticals Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CAD 19.787 million compared to CAD 15.530 million a year ago. Net income was CAD 9.147 million compared to net loss of CAD 1.967 million a year ago. Basic earnings per share from continuing operations was CAD 0.8 compared to basic loss per share from continuing operations of CAD 0.17 a year ago. Diluted earnings per share from continuing operations was CAD 0.1 compared to diluted loss per share from continuing operations of CAD 0.17 a year ago. For the half year, total revenue was CAD 34.209 million compared to CAD 39.891 million a year ago. Net loss was CAD 8.842 million compared to CAD 3.696 million a year ago. Basic loss per share from continuing operations was CAD 0.78 compared to CAD 0.32 a year ago.